Graphic Error on Clonex 2mg Tablets Packages

December 2nd 2020 | Reading time: 1 Min

In collaboration with Israeli Ministry of Health, Teva Pharmaceuticals Industries Ltd, who is marketing Clonex 2mg Tablets, wish to draw the public's attention to a graphic misprint on the side panel of the product's package, on the below listed batches only.

 

The side panel mistakenly mentions, in small font, that each tablet contains 0.5mg. Whereas on its front panels the correct dosage of the product – 2mg, appears clearly, accurately and in large font.

 

It is emphasized that the product itself contains a dosage of 2mg – as it is printed on the front panels of the package and in large font, as well as on the product's blister. The product is safe for use. The barcode is also accurate so there is no practical risk of mistaken dispensing at the pharmacy.

 

Teva is currently making packaging adjustments to correct the misprint in the product's side panel.

Product

SLE Catalogue code

Barcode

Batch number

Expiration date

Clonex 2mg

2CK06010

7290000800585

109692

30/09/2023

Clonex 2mg

2CK06010

7290000800585

109694

30/09/2023

Clonex 2mg

2CK06010

7290000800585

109705

30/09/2023

 

Clonex.jpg

We apologize for the inconvenience this may cause and thank you for your cooperation and understanding.

For any questions or inquiries, please email us at safety.israel@teva.co.il

Sincerely,

Teva Pharmaceutical Industries Ltd. Israel